Status:
COMPLETED
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room
Lead Sponsor:
King Saud University
Collaborating Sponsors:
King Fahad Medical City
Conditions:
Status Asthmaticus
Eligibility:
All Genders
2-12 years
Phase:
PHASE2
PHASE3
Brief Summary
Asthma is the most common chronic illness of childhood. About 10% of children are affected. Not surprisingly, acute asthma exacerbations are one of the common reasons to visit pediatric emergency room...
Detailed Description
Asthma is the most common chronic disease of childhood and the most common cause of admission of children to the hospital. Children in Saudi Arabia have a relatively high prevalence of asthma compared...
Eligibility Criteria
Inclusion
- Children 2-12 years of age with physician diagnosed asthma or a previous episode of SOB that responded well to β2-agonists who present to the ER with moderate or severe asthma exacerbation
Exclusion
- Children with mild asthma exacerbation.
- Children with severe asthma exacerbation who are in critical condition or need immediate intervention.
- Children who have heart disease or chronic lung disease other than asthma.
- Systemic steroids administered within the past 7 days.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
945 Patients enrolled
Trial Details
Trial ID
NCT01524198
Start Date
November 1 2010
End Date
April 1 2012
Last Update
March 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Fahad Medical City
Riyadh, Riyadh Region, Saudi Arabia, 11525